REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/06/2025
Voltar para busca
Dado oficial do USPTO
EFECT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
92
Atualização mais recente
03/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 45
Data de depósito
12/07/2013
Data de registro
02/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/06/2020
Última transação
03/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
VANCOUVER, CA
Examinador
LAM, HAI-LY
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
ZYMEWORKS BC INC.
Zymeworks Inc.
Zymeworks Inc.
Representantes
Sharon R. Smith Morgan, Lewis & Bockius LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Therapeutic, prophylactic preparations, and pharmaceutical preparations and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases, namely, rheumatoid arthritis, Crohn's disease, multiple sclerosis, inflammatory connective tissue diseases, irritable bowel disease, irritable bowel syndrome, colitis, pelvic inflammatory disease, and scleroderma
Classe 42
Scientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, auto immune diseases, inflammatory diseases, and infectious diseases
Classe 45
Licensing of proprietary intellectual property
Publicações
Histórico de despachos e eventos da marca no USPTO.
92 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/03/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
21/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/03/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/03/2020
PUBO
PUBLISHED FOR OPPOSITION
17/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
24/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
24/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
24/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
24/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/01/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
21/01/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/01/2020
GNFR
FINAL REFUSAL E-MAILED
21/01/2020
CNFR
FINAL REFUSAL WRITTEN
21/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/12/2019
ALIE
ASSIGNED TO LIE
30/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/06/2019
GNRT
NON-FINAL ACTION E-MAILED
26/06/2019
CNRT
NON-FINAL ACTION WRITTEN
26/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/06/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
15/01/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
15/01/2019
CNSI
SUSPENSION INQUIRY WRITTEN
15/01/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
15/01/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/06/2018
GNSL
LETTER OF SUSPENSION E-MAILED
28/06/2018
CNSL
SUSPENSION LETTER WRITTEN
28/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/06/2018
ALIE
ASSIGNED TO LIE
22/06/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/06/2018
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
22/12/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
22/12/2017
CNSI
SUSPENSION INQUIRY WRITTEN
22/12/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
19/12/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
17/06/2017
GNSL
LETTER OF SUSPENSION E-MAILED
17/06/2017
CNSL
SUSPENSION LETTER WRITTEN
17/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/06/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
19/12/2016
GNSI
INQUIRY TO SUSPENSION E-MAILED
19/12/2016
CNSI
SUSPENSION INQUIRY WRITTEN
19/12/2016
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
16/12/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/06/2016
GNSL
LETTER OF SUSPENSION E-MAILED
16/06/2016
CNSL
SUSPENSION LETTER WRITTEN
16/06/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/06/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/06/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/06/2016
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
18/12/2015
GNSI
INQUIRY TO SUSPENSION E-MAILED
18/12/2015
CNSI
SUSPENSION INQUIRY WRITTEN
18/12/2015
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
15/12/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
14/06/2015
GNSL
LETTER OF SUSPENSION E-MAILED
14/06/2015
CNSL
SUSPENSION LETTER WRITTEN
14/06/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/05/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/05/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
22/05/2015
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
26/11/2014
GNSI
INQUIRY TO SUSPENSION E-MAILED
26/11/2014
CNSI
SUSPENSION INQUIRY WRITTEN
26/11/2014
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
19/11/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/05/2014
GNSL
LETTER OF SUSPENSION E-MAILED
16/05/2014
CNSL
SUSPENSION LETTER WRITTEN
16/05/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/05/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/05/2014
ALIE
ASSIGNED TO LIE
07/05/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/04/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/10/2013
GNRT
NON-FINAL ACTION E-MAILED
29/10/2013
CNRT
NON-FINAL ACTION WRITTEN
29/10/2013
DOCK
ASSIGNED TO EXAMINER
24/10/2013
MPMK
NOTICE OF PSEUDO MARK E-MAILED
23/07/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/07/2013
NWAP
NEW APPLICATION ENTERED
16/07/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EFECT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.